|

Sonesitatug vedotin Clinical Trials

2 actively recruiting trials across 1 location

▲ +1 trial since June 2026

Also known as: AZD0901, Sone-Ve

Pipeline

Phase 2: 1Phase 3: 1

Top Sponsors

  • Jeeyun Lee1
  • AstraZeneca1

Indications

  • Cancer2
  • Gastroesophageal Junction Adenocarcinoma1
  • Stomach Neoplasms1
  • Gastric Cancer1
  • Esophageal Cancer1

Other1 trial

Perioperative Therapies in Locally Advanced Unresectable Gastric Cancer
Phase 2

Mobile, Alabama1 trial

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

Research Site

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.